• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性浸润性乳腺癌病理及免疫组织化学特征预测:定量与定性超声特征分析的性能比较。

Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis.

机构信息

Department of Medical Ultrasound, Fudan University Shanghai Cancer Center, No 270, Dong'an Road, Xuhui District, Shanghai, 200032, China.

Department of Oncology, Shanghai Medical College, Fudan University, No 270, Dong'an Road, Xuhui District, Shanghai, 200032, China.

出版信息

Eur Radiol. 2022 Mar;32(3):1590-1600. doi: 10.1007/s00330-021-08224-x. Epub 2021 Sep 14.

DOI:10.1007/s00330-021-08224-x
PMID:34519862
Abstract

OBJECTIVE

Sonographic features are associated with pathological and immunohistochemical characteristics of triple-negative breast cancer (TNBC). To predict the biological property of TNBC, the performance using quantitative high-throughput sonographic feature analysis was compared with that using qualitative feature assessment.

METHODS

We retrospectively reviewed ultrasound images, clinical, pathological, and immunohistochemical (IHC) data of 252 female TNBC patients. All patients were subgrouped according to the histological grade, Ki67 expression level, and human epidermal growth factor receptor 2 (HER2) score. Qualitative sonographic feature assessment included shape, margin, posterior acoustic pattern, and calcification referring to the Breast Imaging Reporting and Data System (BI-RADS). Quantitative sonographic features were acquired based on the computer-aided radiomics analysis. Breast cancer masses were manually segmented from the surrounding breast tissues. For each ultrasound image, 1688 radiomics features of 7 feature classes were extracted. The principal component analysis (PCA), least absolute shrinkage and selection operator (LASSO), and support vector machine (SVM) were used to determine the high-throughput radiomics features that were highly correlated to biological properties. The performance using both quantitative and qualitative sonographic features to predict biological properties of TNBC was represented by the area under the receiver operating characteristic curve (AUC).

RESULTS

In the qualitative assessment, regular tumor shape, no angular or spiculated margin, posterior acoustic enhancement, and no calcification were used as the independent sonographic features for TNBC. Using the combination of these four features to predict the histological grade, Ki67, HER2, axillary lymph node metastasis (ALNM), and lymphovascular invasion (LVI), the AUC was 0.673, 0.680, 0.651, 0.587, and 0.566, respectively. The number of high-throughput features that closely correlated with biological properties was 34 for histological grade (AUC 0.942), 27 for Ki67 (AUC 0.732), 25 for HER2 (AUC 0.730), 34 for ALNM (AUC 0.804), and 34 for LVI (AUC 0.795).

CONCLUSION

High-throughput quantitative sonographic features are superior to traditional qualitative ultrasound features in predicting the biological behavior of TNBC.

KEY POINTS

• Sonographic appearances of TNBCs showed a great variety in accordance with its biological and clinical characteristics. • Both qualitative and quantitative sonographic features of TNBCs are associated with tumor biological characteristics. • The quantitative high-throughput feature analysis is superior to two-dimensional sonographic feature assessment in predicting tumor biological property.

摘要

目的

超声特征与三阴性乳腺癌(TNBC)的病理和免疫组织化学特征相关。为了预测 TNBC 的生物学特性,我们比较了使用定量高通量超声特征分析与定性特征评估的性能。

方法

我们回顾性分析了 252 例女性 TNBC 患者的超声图像、临床、病理和免疫组织化学(IHC)数据。所有患者根据组织学分级、Ki67 表达水平和人表皮生长因子受体 2(HER2)评分进行分组。定性超声特征评估包括形状、边界、后向声影模式和钙化,参照乳腺影像报告和数据系统(BI-RADS)。定量超声特征基于计算机辅助放射组学分析获得。从周围乳腺组织手动分割乳腺癌肿块。对于每个超声图像,提取 7 个特征类别的 1688 个放射组学特征。主成分分析(PCA)、最小绝对值收缩和选择算子(LASSO)和支持向量机(SVM)用于确定与生物学特性高度相关的高通量放射组学特征。使用定量和定性超声特征来预测 TNBC 生物学特性的性能由受试者工作特征曲线下面积(AUC)表示。

结果

在定性评估中,规则的肿瘤形状、无角或分叶状边界、后向声增强和无钙化被用作 TNBC 的独立超声特征。使用这四个特征的组合来预测组织学分级、Ki67、HER2、腋窝淋巴结转移(ALNM)和脉管侵犯(LVI),AUC 分别为 0.673、0.680、0.651、0.587 和 0.566。与生物学特性密切相关的高通量特征数量为组织学分级 34 个(AUC 0.942)、Ki67 27 个(AUC 0.732)、HER2 25 个(AUC 0.730)、ALNM 34 个(AUC 0.804)和 LVI 34 个(AUC 0.795)。

结论

高通量定量超声特征优于传统二维超声特征,可预测 TNBC 的生物学行为。

重点

• TNBC 的超声表现与其生物学和临床特征一致,表现出多样性。• TNBC 的定性和定量超声特征均与肿瘤生物学特征相关。• 高通量特征分析优于二维超声特征评估,可预测肿瘤生物学特性。

相似文献

1
Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis.三阴性浸润性乳腺癌病理及免疫组织化学特征预测:定量与定性超声特征分析的性能比较。
Eur Radiol. 2022 Mar;32(3):1590-1600. doi: 10.1007/s00330-021-08224-x. Epub 2021 Sep 14.
2
Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature.三阴性浸润性乳腺癌:超声表现与临床病理特征的关系。
Sci Rep. 2018 Jun 13;8(1):9040. doi: 10.1038/s41598-018-27222-6.
3
Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics.三阴性乳腺癌生存结局评估:基于整合临床病理、超声和钼靶特征的列线图分析。
Eur Radiol. 2022 Oct;32(10):6575-6587. doi: 10.1007/s00330-022-08910-4. Epub 2022 Jun 27.
4
Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.基于动态对比增强 MRI 的放射组学术前预测浸润性乳腺癌的淋巴管血管侵犯。
J Magn Reson Imaging. 2019 Sep;50(3):847-857. doi: 10.1002/jmri.26688. Epub 2019 Feb 17.
5
Radiomics Analysis Based on Automatic Image Segmentation of DCE-MRI for Predicting Triple-Negative and Nontriple-Negative Breast Cancer.基于 DCE-MRI 自动图像分割的放射组学分析预测三阴性和非三阴性乳腺癌。
Comput Math Methods Med. 2021 Aug 10;2021:2140465. doi: 10.1155/2021/2140465. eCollection 2021.
6
Prediction of Axillary Lymph Node Metastasis in Early-stage Triple-Negative Breast Cancer Using Multiparametric and Radiomic Features of Breast MRI.基于多参数和乳腺 MRI 影像组学特征预测早期三阴性乳腺癌腋窝淋巴结转移
Acad Radiol. 2023 Sep;30 Suppl 2:S25-S37. doi: 10.1016/j.acra.2023.05.025. Epub 2023 Jun 16.
7
Prediction of Lymph Node Metastasis in Patients With Papillary Thyroid Carcinoma: A Radiomics Method Based on Preoperative Ultrasound Images.甲状腺乳头状癌患者淋巴结转移的预测:一种基于术前超声图像的影像组学方法
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819831713. doi: 10.1177/1533033819831713.
8
BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.BI-RADS 超声词汇描述符与三阴性乳腺癌间质肿瘤浸润淋巴细胞。
Acad Radiol. 2022 Jan;29 Suppl 1(Suppl 1):S35-S41. doi: 10.1016/j.acra.2021.06.007. Epub 2021 Jul 14.
9
Ultrasonographic appearance of triple-negative invasive breast carcinoma is associated with novel molecular subtypes based on transcriptomic analysis.基于转录组分析,三阴性浸润性乳腺癌的超声表现与新的分子亚型相关。
Ann Transl Med. 2020 Apr;8(7):435. doi: 10.21037/atm.2020.03.204.
10
Radiomics of US texture features in differential diagnosis between triple-negative breast cancer and fibroadenoma.超声纹理特征在三阴性乳腺癌与纤维腺瘤鉴别诊断中的放射组学研究。
Sci Rep. 2018 Sep 10;8(1):13546. doi: 10.1038/s41598-018-31906-4.

引用本文的文献

1
Intratumoral and peritumoral ultrasound radiomics analysis for predicting HER2-low expression in HER2-negative breast cancer patients: a retrospective analysis of dual-central study.用于预测HER2阴性乳腺癌患者HER2低表达的瘤内和瘤周超声影像组学分析:一项双中心研究的回顾性分析
Discov Oncol. 2025 Jun 5;16(1):1007. doi: 10.1007/s12672-025-02752-4.
2
Intratumoral and peritumoral ultrasound-based radiomics for preoperative prediction of HER2-low breast cancer: a multicenter retrospective study.基于肿瘤内和肿瘤周围超声的影像组学用于术前预测HER2低表达乳腺癌:一项多中心回顾性研究
Insights Imaging. 2025 Mar 7;16(1):53. doi: 10.1186/s13244-025-01934-6.
3

本文引用的文献

1
Sonographic Features of Triple-Negative Breast Carcinomas Are Correlated With mRNA-lncRNA Signatures and Risk of Tumor Recurrence.三阴性乳腺癌的超声特征与mRNA-lncRNA特征及肿瘤复发风险相关。
Front Oncol. 2021 Jan 19;10:587422. doi: 10.3389/fonc.2020.587422. eCollection 2020.
2
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial.分子亚型分类和基因组分析在难治性转移性三阴性乳腺癌的精准医学中扩展:FUTURE 试验。
Cell Res. 2021 Feb;31(2):178-186. doi: 10.1038/s41422-020-0375-9. Epub 2020 Jul 27.
3
A preliminary study to quantitatively evaluate the development of maturation degree for fetal lung based on transfer learning deep model from ultrasound images.
Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis.
基于超声的人工智能预测乳腺癌关键分子标志物的诊断性能:系统评价和荟萃分析。
PLoS One. 2024 May 31;19(5):e0303669. doi: 10.1371/journal.pone.0303669. eCollection 2024.
4
Artificial intelligence-based, semi-automated segmentation for the extraction of ultrasound-derived radiomics features in breast cancer: a prospective multicenter study.基于人工智能的半自动分割法在乳腺癌超声影像组学特征提取中的应用:一项前瞻性多中心研究。
Radiol Med. 2024 Jul;129(7):977-988. doi: 10.1007/s11547-024-01826-7. Epub 2024 May 9.
5
Contrast-enhanced ultrasound for the preoperative prediction of pathological characteristics in breast cancer.超声造影用于乳腺癌病理特征的术前预测
Front Oncol. 2024 Feb 29;14:1320714. doi: 10.3389/fonc.2024.1320714. eCollection 2024.
6
Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer.用于预测乳腺癌分子生物标志物的基于超声的放射组学模型。
Front Oncol. 2023 Jul 31;13:1216446. doi: 10.3389/fonc.2023.1216446. eCollection 2023.
7
A Review of AI-Based Radiomics and Computational Pathology Approaches in Triple-Negative Breast Cancer: Current Applications and Perspectives.基于人工智能的放射组学和计算病理学在三阴性乳腺癌中的研究进展:当前的应用与展望。
Clin Breast Cancer. 2023 Dec;23(8):800-812. doi: 10.1016/j.clbc.2023.06.004. Epub 2023 Jun 21.
8
Ultrasound radiomics in personalized breast management: Current status and future prospects.个性化乳腺管理中的超声影像组学:现状与未来展望
Front Oncol. 2022 Aug 17;12:963612. doi: 10.3389/fonc.2022.963612. eCollection 2022.
9
Nomograms predicting recurrence in patients with triple negative breast cancer based on ultrasound and clinicopathological features.基于超声及临床病理特征的三阴性乳腺癌患者复发预测列线图
Br J Radiol. 2022 Sep 1;95(1138):20220305. doi: 10.1259/bjr.20220305. Epub 2022 Aug 2.
10
Radiomics Based on Digital Mammography Helps to Identify Mammographic Masses Suspicious for Cancer.基于数字乳腺摄影的放射组学有助于识别可疑为癌症的乳腺X线摄影肿块。
Front Oncol. 2022 Apr 1;12:843436. doi: 10.3389/fonc.2022.843436. eCollection 2022.
基于超声图像的迁移学习深度模型对胎儿肺成熟度发育程度的定量评估初步研究。
Int J Comput Assist Radiol Surg. 2020 Aug;15(8):1407-1415. doi: 10.1007/s11548-020-02211-1. Epub 2020 Jun 15.
4
Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.三阴性乳腺癌的免疫组化分子分型:分子基础与临床相关性。
Oncologist. 2020 Oct;25(10):e1481-e1491. doi: 10.1634/theoncologist.2019-0982. Epub 2020 Jun 1.
5
Ultrasonographic appearance of triple-negative invasive breast carcinoma is associated with novel molecular subtypes based on transcriptomic analysis.基于转录组分析,三阴性浸润性乳腺癌的超声表现与新的分子亚型相关。
Ann Transl Med. 2020 Apr;8(7):435. doi: 10.21037/atm.2020.03.204.
6
Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer.深度学习放射组学可预测早期乳腺癌腋窝淋巴结状态。
Nat Commun. 2020 Mar 6;11(1):1236. doi: 10.1038/s41467-020-15027-z.
7
Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer.具有垂直定向特征的超声检查可预测三阴性乳腺癌的预后更差。
Breast. 2020 Feb;49:33-40. doi: 10.1016/j.breast.2019.10.006. Epub 2019 Oct 23.
8
Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.乳腺 MRI 背景实质增强作为连接分子肿瘤亚型的影像学桥梁。
Eur J Radiol. 2019 Apr;113:148-152. doi: 10.1016/j.ejrad.2019.02.018. Epub 2019 Feb 15.
9
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.三阴性乳腺癌的基因组和转录组全景:亚型和治疗策略。
Cancer Cell. 2019 Mar 18;35(3):428-440.e5. doi: 10.1016/j.ccell.2019.02.001. Epub 2019 Mar 7.
10
Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.Tinagl1 通过同时抑制整合素/FAK 和 EGFR 信号来抑制三阴性乳腺癌的进展和转移。
Cancer Cell. 2019 Jan 14;35(1):64-80.e7. doi: 10.1016/j.ccell.2018.11.016. Epub 2019 Jan 3.